Manufacturing Challenges for Novel Antibody-based Modalities
This Summit will explore topics such as:
•What paradigms can be adopted from traditional mAb manufacturing and what unique challenges must be overcome?
•What are the outstanding gaps in analytical technologies needed to assess product quality for these modalities?
•How do drug development and process development work together to ensure manufacturability of these novel modalities?
•How are the novel formulation challenges being addressed?
•What approaches are manufacturers taking to solve the cold chain challenges?
The 2025 BioMAN Summit will bring together leading experts from industry, academia, and regulatory agencies to address the pressing manufacturing challenges of novel antibody-based modalities.
Stay tuned—registration will open soon. Be sure to check back for updates and to reserve your spot.